Logotype for Teladoc Health Inc

Teladoc Health (TDOC) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Teladoc Health Inc

Q3 2026 earnings summary

29 Oct, 2026

Executive summary

  • Q3 revenue was $605.1M, down 3% YoY; net loss narrowed to $26.9M, or $0.15/share, while adjusted EBITDA rose 14% to $79.4M.

  • Integrated Care growth and higher insurance revenue partly offset BetterHelp cash-pay declines; results were near the high end of revenue guidance and above adjusted EBITDA guidance.

Financial highlights

  • Q3 adjusted EBITDA margin was 13.1%, versus 11.2% a year earlier; operating loss narrowed to $28.1M from $52.0M.

  • Q3 operating cash flow was $106.5M and free cash flow was $75.9M; nine-month free cash flow was $85.4M versus $113.5M.

  • Nine-month revenue declined 3% to $1.826B; net loss narrowed to $129.7M and adjusted EBITDA increased 3% to $203.2M.

  • Q3 advertising and marketing expense fell 26% to $124.0M, primarily due to lower BetterHelp digital and media spending.

Outlook and guidance

  • FY 2026 revenue guidance is $2,395M–$2,441M and adjusted EBITDA guidance is $277M–$303M; free cash flow guidance is $135M–$165M.

  • FY 2026 net loss per share guidance is $0.95–$0.75; Q4 revenue guidance is $569M–$615M, adjusted EBITDA is $74M–$100M, and net loss per share is $0.23–$0.03.

  • FY and Q4 U.S. Integrated Care member outlook is 99.5M–100.5M.

  • BetterHelp’s 2026 outlook was materially reduced; cash-pay declines are not expected to be fully offset by insurance revenue.

  • 2027 BetterHelp goal: sequential quarterly insurance growth and an exit annualized revenue run rate of at least $200M; full-year advertising spend expected to decline in the mid-to-high 20% range.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Teladoc Health